In the US, Aripiprazole (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Autism, Bipolar Disorder, Depression, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder, Schizophrenia and Tourette's Syndrome.
US matches:
- Aripiprazole
- Aripiprazole Orally Disintegrating Tablets
- Aripiprazole Solution
- Aripiprazole Tablets
- Aripiprazole Intramuscular
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05AX12
CAS registry number (Chemical Abstracts Service)
0129722-12-9
Chemical Formula
C23-H27-Cl2-N3-O2
Molecular Weight
448
Therapeutic Category
Neuroleptic
Chemical Names
2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro- (USAN)
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril (WHO)
7-{4-[4-(2,3-Dichlorphenyl)piperazin-1-yl]butoxy}-3,4-dihydro-1H-chinolin-2-on (IUPAC)
Foreign Names
- Aripiprazolum (Latin)
- Aripiprazol (German)
- Aripiprazole (French)
- Aripiprazol (Spanish)
Generic Names
- Aripiprazole (OS: USAN, BAN)
- Abilitat (IS)
- OPC 14597 (IS: Otsuka)
- OPC 31 (IS: Otsuka)
Brand Names
- Abilify
Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; Otsuka, Austria; Otsuka, Czech Republic; Otsuka, Germany; Otsuka, Denmark; Otsuka, France; Otsuka, Greece; Otsuka, Hong Kong; Otsuka, Hungary; Otsuka, Indonesia; Otsuka, Iceland; Otsuka, Japan; Otsuka, Luxembourg; Otsuka, Norway; Otsuka, Philippines; Otsuka, Slovakia; Otsuka, Thailand; Otsuka, United States; Otsuka Pharma, Tunisia; Otsuka Pharmaceuticals, United Kingdom - Arip
Torrent, Myanmar - Aripen
Opsonin, Bangladesh - Aripra
Incepta, Bangladesh - Ariprazole
General Pharma, Bangladesh - Arlemide
Rontag, Argentina - Azymol
Drugtech-Recalcine, Chile - Brisking
Kanghong, China - Groven
Filaxis, Argentina - Ilimit
Pharma Investi, Chile; Roemmers, Peru - Irazem
Roemmers, Argentina - Otsuka Albilify
Otsuka, Taiwan - Real One
Nicholas, India - Siblix
Beta, Argentina - Siznil
Orion, Bangladesh - Sizorpa
Acme, Bangladesh
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment